![Barbara Savoldo, MD, PhD](https://news.unchealthcare.org/wp-content/uploads/sites/1159/2020/08/excellent-research-results-for-car-t-cell-therapy-against-hodgkin-lymphoma-image2-scaled-1-600x400.jpeg)
July 24, 2020
Excellent Research Results for CAR-T Cell Therapy Against Hodgkin Lymphoma
UNC Lineberger researchers demonstrated that patients with advanced, relapsed/refractory forms of the common blood cancer showed a high rate of durable responses to CAR-T cell immunotherapy.